抗生素耐药性 / Antibiotic Resistance

抗生素是一类能够杀死或抑制细菌生长的化学物质，在现代医学中发挥着不可替代的作用。自1928年亚历山大·弗莱明意外发现青霉素以来，抗生素已挽救了无数生命，使曾经致命的手术、分娩和感染变得可控。抗生素通过靶向细菌特有的结构或代谢途径发挥作用：例如青霉素抑制细胞壁合成，四环素阻断蛋白质合成，而环丙沙星干扰DNA复制。然而，随着抗生素的广泛使用甚至滥用，细菌逐渐进化出抵抗机制，导致抗菌素耐药性（Antimicrobial Resistance, AMR）成为全球公共卫生的重大威胁，世界卫生组织将其列为人类面临的十大健康威胁之一。

Antibiotics are chemical substances that kill or inhibit the growth of bacteria, playing an irreplaceable role in modern medicine. Since Alexander Fleming’s accidental discovery of penicillin in 1928, antibiotics have saved countless lives, making once-fatal procedures such as surgery, childbirth, and infections manageable. Antibiotics work by targeting structures or metabolic pathways unique to bacteria: for example, penicillin inhibits cell wall synthesis, tetracycline blocks protein synthesis, and ciprofloxacin interferes with DNA replication. However, with widespread and sometimes excessive use, bacteria have gradually evolved resistance mechanisms, making antimicrobial resistance (AMR) one of the greatest global public health threats ： the World Health Organization ranks it among the top ten health threats facing humanity.

抗生素的分类：杀菌性与抑菌性 / Classifying Antibiotics: Bactericidal vs Bacteriostatic

抗生素可根据其对细菌的作用方式分为两大类：杀菌性抗生素（bactericidal）直接杀死细菌，而抑菌性抗生素（bacteriostatic）仅阻止细菌生长和繁殖，依赖宿主免疫系统清除已存在的病原体。青霉素及其衍生物（如阿莫西林、甲氧西林）属于杀菌性抗生素，其β-内酰胺环不可逆地结合转肽酶，阻断肽聚糖交联，导致细胞壁在渗透压作用下破裂。相反，四环素和氯霉素属于抑菌性抗生素，它们与细菌核糖体的30S或50S亚基结合，阻止tRNA进入A位点或抑制肽键形成，从而可逆地阻断蛋白质合成。理解这一区别在临床上至关重要：同时使用杀菌性和抑菌性抗生素可能产生拮抗作用，因为抑菌性药物使细菌停止生长后，许多杀菌性抗生素（靶向活跃分裂的细胞壁合成）的效力会显著降低。

Antibiotics can be divided into two broad categories based on their mode of action: bactericidal antibiotics directly kill bacteria, while bacteriostatic antibiotics merely prevent bacterial growth and replication, relying on the host immune system to clear existing pathogens. Penicillin and its derivatives (such as amoxicillin and methicillin) are bactericidal ： their β-lactam ring irreversibly binds transpeptidase enzymes, blocking peptidoglycan cross-linking and causing the cell wall to rupture under osmotic pressure. In contrast, tetracycline and chloramphenicol are bacteriostatic ： they bind to the 30S or 50S subunit of the bacterial ribosome, preventing tRNA entry into the A-site or inhibiting peptide bond formation, thereby reversibly blocking protein synthesis. Understanding this distinction is clinically crucial: administering bactericidal and bacteriostatic antibiotics simultaneously can produce antagonism, because once bacteriostatic drugs halt bacterial growth, many bactericidal antibiotics that target actively dividing cell-wall synthesis lose much of their effectiveness.

抗生素的作用机制 / Mechanisms of Antibiotic Action

抗生素通过多种机制选择性靶向细菌，利用原核细胞与真核细胞之间的结构差异实现选择性毒性。抑制细胞壁合成是最常见的一类机制：青霉素和头孢菌素中的β-内酰胺环模拟D-Ala-D-Ala二肽结构，与转肽酶的活性位点丝氨酸残基共价结合，不可逆地抑制肽聚糖交联，使细菌因渗透压失衡而裂解。万古霉素则通过不同的途径：与D-Ala-D-Ala末端直接形成五个氢键，物理阻断转肽酶和转糖基酶的作用。第二类机制涉及蛋白质合成抑制：氨基糖苷类（如链霉素）与30S核糖体亚基结合导致mRNA误读，大环内酯类（如红霉素）与50S亚基结合阻断多肽链的延伸通道。第三类机制是抑制核酸合成或功能：氟喹诺酮类（如环丙沙星）抑制DNA旋转酶和拓扑异构酶IV，阻止DNA超螺旋和解旋，从而阻断复制；利福平则直接抑制细菌RNA聚合酶，阻止转录过程。第四类机制涉及破坏细胞膜完整性：多粘菌素通过与脂多糖和磷脂的脂肪酸成分相互作用，破坏革兰氏阴性菌外膜的渗透屏障功能，导致细胞内容物泄漏和死亡。

Antibiotics target bacteria selectively through diverse mechanisms, exploiting structural differences between prokaryotic and eukaryotic cells to achieve selective toxicity. Cell-wall synthesis inhibition is the most common class of mechanism: the β-lactam ring in penicillin and cephalosporins mimics the D-Ala-D-Ala dipeptide structure, covalently binding to the active-site serine residue of transpeptidase enzymes and irreversibly inhibiting peptidoglycan cross-linking, causing the bacterium to lyse from osmotic imbalance. Vancomycin works through a different route ： it forms five hydrogen bonds directly with the D-Ala-D-Ala terminus, physically blocking both transpeptidase and transglycosylase action. The second class involves protein synthesis inhibition: aminoglycosides (such as streptomycin) bind the 30S ribosomal subunit and cause mRNA misreading, while macrolides (such as erythromycin) bind the 50S subunit and block the polypeptide exit tunnel. The third class inhibits nucleic acid synthesis or function: fluoroquinolones (such as ciprofloxacin) inhibit DNA gyrase and topoisomerase IV, preventing DNA supercoiling and unwinding, thereby blocking replication; rifampicin directly inhibits bacterial RNA polymerase, halting transcription. The fourth class disrupts cell membrane integrity: polymyxins interact with the fatty acid components of lipopolysaccharides and phospholipids, breaking the permeability barrier function of the Gram-negative outer membrane, causing leakage of cell contents and death.

抗菌素耐药性的主要机制 / Major Mechanisms of Antimicrobial Resistance

细菌通过四种主要机制获得对抗生素的耐药性。第一种是酶促降解或修饰：β-内酰胺酶（如TEM-1、CTX-M广谱β-内酰胺酶）水解β-内酰胺环使青霉素和头孢菌素失效；氨基糖苷修饰酶（乙酰转移酶、磷酸转移酶、腺苷转移酶）通过添加化学基团改变抗生素结构，使其无法结合核糖体靶点。第二种是靶点修饰：例如，耐甲氧西林金黄色葡萄球菌（MRSA）获得了mecA基因，编码一种变异的青霉素结合蛋白PBP2a：该蛋白对几乎所有β-内酰胺类抗生素的亲和力极低，使得青霉素、头孢菌素和碳青霉烯类全部无效。第三种是药物外排泵：细菌膜上的转运蛋白（如大肠杆菌中的AcrAB-TolC系统、铜绿假单胞菌中的MexAB-OprM）主动将抗生素从细胞质中泵出，降低细胞内药物浓度至低于治疗阈值。第四种是降低膜通透性：革兰氏阴性菌通过下调外膜孔蛋白（porin）的表达减少抗生素进入：例如，铜绿假单胞菌下调OprD孔蛋白后对碳青霉烯类的摄取显著降低，产生临床水平的耐药性。

Bacteria acquire resistance to antibiotics through four major mechanisms. The first is enzymatic degradation or modification: β-lactamases (such as TEM-1 and CTX-M extended-spectrum β-lactamases) hydrolyse the β-lactam ring, inactivating penicillin and cephalosporins; aminoglycoside-modifying enzymes (acetyltransferases, phosphotransferases, adenylyltransferases) alter antibiotic structure by adding chemical groups, preventing ribosomal target binding. The second is target modification: for example, methicillin-resistant Staphylococcus aureus (MRSA) has acquired the mecA gene, which encodes an altered penicillin-binding protein, PBP2a ： this protein has extremely low affinity for virtually all β-lactam antibiotics, rendering penicillin, cephalosporins, and carbapenems ineffective. The third is drug efflux pumps: transport proteins on the bacterial membrane (such as the AcrAB-TolC system in Escherichia coli and MexAB-OprM in Pseudomonas aeruginosa) actively pump antibiotics out of the cytoplasm, reducing intracellular drug concentrations below therapeutic thresholds. The fourth is reduced membrane permeability: Gram-negative bacteria downregulate outer-membrane porin expression to decrease antibiotic entry ： for example, Pseudomonas aeruginosa downregulates the OprD porin, significantly reducing carbapenem uptake and producing clinically relevant resistance.

耐药性的遗传基础 / The Genetic Basis of Resistance

抗菌素耐药性可以通过两种遗传途径产生。第一种是染色体基因的自发突变：细菌在复制过程中以约10⁻⁸至10⁻⁹每个基因每代的频率发生随机突变，其中一些突变恰好改变抗生素靶点或上调外排泵表达。例如，结核分枝杆菌RNA聚合酶基因rpoB中的单个点突变（第531位丝氨酸被亮氨酸替换）就对利福平产生高水平耐药性。第二种途径：在临床上更为重要：是水平基因转移（HGT），它使耐药基因在细菌物种间甚至跨属传播。HGT通过三种机制实现：转化（细菌从环境中摄取游离的DNA片段，如经过热灭活的耐青霉素链球菌释放的DNA被活菌吸收）、转导（噬菌体在感染过程中将供体菌的质粒或染色体DNA片段携带至受体菌）和接合（供体菌通过性菌毛与受体菌直接接触，将携带耐药基因的接合质粒：如含有多个耐药基因盒的R质粒：传递给受体菌）。

Antimicrobial resistance can arise through two genetic pathways. The first is spontaneous mutation in chromosomal genes: bacteria undergo random mutations during replication at a frequency of approximately 10⁻⁸ to 10⁻⁹ per gene per generation, and some of these mutations happen to alter antibiotic targets or upregulate efflux pump expression. For example, a single point mutation in the rpoB gene of Mycobacterium tuberculosis (serine at position 531 substituted by leucine) produces high-level resistance to rifampicin. The second pathway ： clinically more significant ： is horizontal gene transfer (HGT), which enables resistance genes to spread between bacterial species and even across genera. HGT occurs through three mechanisms: transformation (bacteria take up free DNA fragments from the environment, such as DNA released from heat-killed penicillin-resistant streptococci being absorbed by live bacteria), transduction (bacteriophages carry plasmid or chromosomal DNA fragments from donor to recipient bacteria during infection), and conjugation (direct cell-to-cell contact via a sex pilus transfers conjugative plasmids ： such as R plasmids carrying multiple resistance gene cassettes ： from donor to recipient).

抗生素与自然选择：耐药性的进化 / Antibiotics and Natural Selection: The Evolution of Resistance

抗菌素耐药性的出现和传播是自然选择在微生物层面运行的经典实例。在一个细菌种群中，由于随机突变或水平基因转移，极少数的个体可能携带耐药基因。当抗生素存在时：构成强大的选择压力：敏感的细菌被杀死或抑制，而耐药变体存活并繁殖，将其耐药基因传递给后代。这就是达尔文式选择的直接体现：抗生素环境充当”选择剂”，耐药等位基因的频率在种群中迅速上升。农业中抗生素的广泛使用加剧了这一过程：全球约70%的抗生素用于畜牧业，主要用于促进生长和预防密集饲养条件下的疾病，这为耐药菌株的富集和传播创造了巨大的选择性环境。此外，抗生素耐药基因可以在环境细菌和人类病原体之间交换，因为土壤和水生环境中的天然抗生素生产者（如链霉菌属）携带了大量自古以来就存在的耐药基因：这些基因构成了”耐药基因库”（resistome），通过HGT进入临床相关菌株的路径早已存在。

The emergence and spread of antimicrobial resistance is a classic example of natural selection operating at the microbial level. Within a bacterial population, a tiny minority of individuals may carry resistance genes due to random mutation or horizontal gene transfer. When antibiotics are present ： exerting powerful selective pressure ： susceptible bacteria are killed or inhibited, while resistant variants survive and reproduce, passing their resistance genes to offspring. This is natural selection in direct action: the antibiotic environment serves as the selecting agent, and the frequency of resistance alleles rises rapidly in the population. The widespread use of antibiotics in agriculture exacerbates this process: approximately 70% of the world’s antibiotics are used in livestock production, primarily for growth promotion and disease prevention under intensive farming conditions, creating an enormous selective landscape for the enrichment and dissemination of resistant strains. Furthermore, antibiotic resistance genes can be exchanged between environmental bacteria and human pathogens, because natural antibiotic producers in soil and aquatic environments (such as Streptomyces species) carry vast reservoirs of resistance genes that have existed since ancient times ： this resistome provides a pre-existing genetic pool from which clinically relevant strains can acquire resistance through HGT.

MRSA与ESBL：临床上的超级细菌 / MRSA and ESBL: Clinical Superbugs

耐甲氧西林金黄色葡萄球菌（MRSA）是院内感染中最具代表性的多重耐药菌之一。MRSA菌株携带的mecA基因位于葡萄球菌染色体盒mec（SCCmec）：一个可移动的遗传元件上，编码PBP2a蛋白。由于PBP2a对β-内酰胺类抗生素的亲和力比正常PBP低约1000倍，MRSA对包括青霉素、头孢菌素和碳青霉烯类在内的几乎所有β-内酰胺类耐药。治疗选择极为有限：万古霉素、利奈唑胺和达托霉素是最后防线药物，而万古霉素中介金黄色葡萄球菌（VISA）和万古霉素耐药金黄色葡萄球菌（VRSA）的出现：后者通过从肠球菌获得vanA基因簇：意味着即使这些保留药物也在失效。另一类临床重要威胁是产广谱β-内酰胺酶（ESBL）的肠杆菌科细菌：大肠杆菌和肺炎克雷伯菌产生的CTX-M型ESBL能够水解第三代头孢菌素（如头孢曲松、头孢他啶），使这些一线药物失效。碳青霉烯类曾是对抗ESBL菌株的最后选择，但碳青霉烯酶（如KPC和NDM-1金属-β-内酰胺酶）的出现意味着我们正进入一个后抗生素时代，少数感染已对所有可用抗生素产生泛耐药性。

Methicillin-resistant Staphylococcus aureus (MRSA) is among the most emblematic multi-drug-resistant organisms in hospital-acquired infections. MRSA strains carry the mecA gene on the staphylococcal cassette chromosome mec (SCCmec) ： a mobile genetic element ： encoding the PBP2a protein. Because PBP2a has approximately 1000-fold lower affinity for β-lactam antibiotics compared to normal PBPs, MRSA is resistant to virtually all β-lactams, including penicillin, cephalosporins, and carbapenems. Treatment options are extremely limited: vancomycin, linezolid, and daptomycin are last-resort drugs, and the emergence of vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA) ： the latter acquiring the vanA gene cluster from enterococci ： means even these reserve agents are failing. Another clinically significant threat is ESBL-producing Enterobacteriaceae: Escherichia coli and Klebsiella pneumoniae produce CTX-M-type extended-spectrum β-lactamases capable of hydrolysing third-generation cephalosporins (such as ceftriaxone and ceftazidime), rendering these first-line drugs ineffective. Carbapenems were once the last option against ESBL strains, but the emergence of carbapenemases (such as KPC and NDM-1 metallo-β-lactamase) signals that we are entering a post-antibiotic era, where a small number of infections already exhibit pan-resistance to all available antibiotics.

减少耐药性：抗生素管理 / Reducing Resistance: Antibiotic Stewardship

减缓抗菌素耐药性蔓延需要多层次、多部门协调的策略，核心是抗生素管理（antimicrobial stewardship）。在临床层面，医生必须遵循”合理使用”原则：仅在细菌感染确诊或高度怀疑时开具抗生素，根据药敏试验结果选择窄谱而非广谱抗生素，并确保患者完成整个疗程：过早停药可能使部分耐药菌存活，而过长疗程则增加选择压力和不良反应风险。在农业层面，许多国家已禁止将医学上重要的抗生素用作生长促进剂：欧盟于2006年全面禁止，中国于2020年禁止在饲料中添加除中药外的所有促生长抗生素。在公共卫生层面，提高疫苗接种覆盖率可减少感染发生从而降低抗生素需求，改善医院感染控制措施（手部卫生、隔离、环境清洁）可阻断耐药菌的院内传播。在研发层面，需要新的经济激励来吸引制药公司重返抗生素研发领域：自1980年代以来，仅有两种全新的抗生素类别被发现，而针对革兰氏阴性菌的新型抗生素的研发管道尤其枯竭。

Slowing the spread of antimicrobial resistance requires a multi-level, multi-sectoral coordinated strategy, with antibiotic stewardship at its core. At the clinical level, prescribers must follow principles of judicious use: prescribe antibiotics only when bacterial infection is confirmed or strongly suspected, select narrow-spectrum over broad-spectrum agents based on sensitivity testing results, and ensure patients complete the full course ： stopping too early may allow partially resistant bacteria to survive, while excessively long courses increase selection pressure and adverse effect risk. At the agricultural level, many countries have banned the use of medically important antibiotics as growth promoters: the European Union instituted a complete ban in 2006, and China banned all growth-promoting antibiotics (except traditional Chinese medicine) in animal feed from 2020. At the public health level, increasing vaccination coverage reduces infection incidence and thereby antibiotic demand, while improved hospital infection control measures (hand hygiene, isolation, environmental cleaning) interrupt nosocomial transmission of resistant organisms. At the research level, new economic incentives are needed to attract pharmaceutical companies back into antibiotic development ： since the 1980s, only two entirely new antibiotic classes have been discovered, and the pipeline for novel antibiotics targeting Gram-negative bacteria is particularly depleted.

核心双语术语 / Key Bilingual Terms

考试技巧 / Exam Tips

在A-Level生物学考试中，抗菌素耐药性通常以数据解释题或论述题形式出现。当题目提供表格或图表数据（如耐药菌株比例随时间变化的折线图或抗生素使用量与耐药率的相关性散点图），务必将数据趋势与自然选择原理结合作答：描述数据：”随着青霉素使用量从2000年每年50吨增加到2010年每年200吨，耐青霉素肺炎链球菌的比例从2%上升至38%”：然后用选择压力（抗生素） = 耐药变体存活 = 繁殖 = 等位基因频率上升的框架进行解释。论述题中务必使用准确的生物学术语：不要说”细菌变得耐药”，而应使用”携带耐药等位基因的变体在抗生素施加的选择压力下具有更高的适应性因而被自然选择筛选出来”。涉及水平基因转移时，区分三种机制并指出接合通过接合质粒实现是临床上最重要的耐药基因传播方式。如果讨论农业抗生素使用的论述题，必须提及选择压力环境和人类病原体通过食物链获得耐药基因的路径。

In A-Level Biology exams, antimicrobial resistance typically appears in data-interpretation or essay-style questions. When presented with tabular or graphical data (such as line graphs showing resistant strain proportions over time, or scatter plots correlating antibiotic consumption with resistance rates), always connect data trends with natural selection principles: describe the data ： “as penicillin usage increased from 50 tonnes per year in 2000 to 200 tonnes per year in 2010, the proportion of penicillin-resistant Streptococcus pneumoniae rose from 2% to 38%” ： then explain using the framework of selective pressure (antibiotic) = resistant variant survival = reproduction = rise in allele frequency. In essay questions, always use precise biological terminology: do not say “bacteria become resistant” ： use “variants carrying resistance alleles have higher fitness under the selective pressure exerted by the antibiotic and are therefore selected for by natural selection.” When discussing horizontal gene transfer, distinguish the three mechanisms and note that conjugation via conjugative plasmids is the clinically most significant route of resistance gene dissemination. If the essay discusses agricultural antibiotic use, you must mention the selective pressure landscape and the pathway by which human pathogens can acquire resistance genes through the food chain.

抗生素耐药性 / Antibiotic Resistance